ParisK: Correlation of Imaging Techniques With Histology
ParisK
The Assessment of the Plaque at RISK by Non-invasive (Molecular) Imaging and Modelling (ParisK): Correlation of Imaging Techniques With Histology
1 other identifier
observational
60
1 country
1
Brief Summary
The possibility to identify the risk of rupture of a carotid plaque will have tremendous impact in clinical decision making. A vulnerable plaque is considered to have a large lipid rich necrotic core (LRNC), a thin fibrous cap, the presence of inflammatory cells, intraplaque haemorrhage and/or neovascularisation (vasa vasorum). The investigators aim to validate imaging of plaque vulnerability with histology. Previous studies have evaluated the use of imaging to assess carotid plaque vulnerability, mostly showing a good correlation between imaging and histology and/or clinical characteristics. However, they have focused on single modalities, (magnetic resonance imaging \[MRI\], multidetector-row computed tomography (MDCT), ultrasonography (US) or transcranial Doppler (TCD), and have used relatively small cohorts The primary goal of this study is to investigate whether there is a correlation between neovascularisation in the carotid atherosclerotic plaque as observed with 3.0 Tesla dynamic contrast-enhanced MRI and histology. Moreover, the investigators aim to investigate the correlation between the volume of the LRNC as determined by dual-energy CT and histology. Secondly, the investigators will investigate the correlation between the volume of the LRNC, the fibrous cap status and the volume of the calcifications determined by MRI versus histology, the correlation between number of microembolisms and fibrous cap status and the correlation between the deformation pattern seen with ultrasound and the volume of the LRNC. The imaging parameters showing good correlation with plaque vulnerability characteristics can be used for further analysis in assessing the vulnerable plaque
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 16, 2012
CompletedFirst Posted
Study publicly available on registry
October 17, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedOctober 27, 2023
October 1, 2023
3.3 years
October 16, 2012
October 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Ktrans on dynamic contrast-enhanced (DCE)-MRI
The correlation between neovascularisation in carotid atherosclerotic plaque as assessed by dynamic 3.0 Tesla MRI and microvasculature as assessed by histology.
1 day
Lipid-rich necrotic core on dual-energy CT
The correlation between the size of lipid-rich-necrotic-core in dual-energy CT and histology.
1 day
Secondary Outcomes (3)
deformation pattern on ultrasound
1 day
number of recorded micro embolic signals (MES)
1 day
Volume of LRNC and calcifications and fibrous cap status on MRI
1 day
Study Arms (1)
Patients scheduled for CEA
All patients who are scheduled for carotid endarterectomy (CEA)
Interventions
Multi-sequence MR protocol
Eligibility Criteria
Patients with a carotid artery stenosis, who are scheduled for carotid endarterectomy, will be included.
You may qualify if:
- Patients with a carotid artery stenosis, who are scheduled for carotid endarterectomy
- Age 18 years or older (no maximum age)
- Informed consent by signing informed consent form regarding this study
- Symptomatic carotid artery stenosis 70-99% within 3 months of neurological symptoms
- Symptomatic carotid artery stenosis 50-99% in man within 2 weeks of neurological symptoms
- Asymptomatic carotid artery stenosis 70-99% with contralateral occlusion
You may not qualify if:
- Severe co-morbidity, dementia or pregnancy
- Standard contra-indications for MRI (ferromagnetic implants like pacemakers or other electronic implants, metallic eye fragments, vascular clips, claustrophobia, etc.)
- Patients who have a documented allergy to MRI or CT contrast media
- Patients with a renal clearance \<30 ml/min are not eligible to undergo contrast-enhanced MRI
- Patients with a renal clearance \<60 ml/min are not eligible to undergo CT
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maastricht University Medical Centerlead
- Center for Translational Molecular Medicinecollaborator
- Dutch Heart Foundationcollaborator
Study Sites (1)
Maastricht University Medical Center
Maastricht, Limburg, Netherlands
Related Publications (3)
Aizaz M, Bierens J, Gijbels MJJ, Schreuder THCML, van Orshoven NP, Daemen JHC, Mess WH, Flohr T, van Oostenbrugge RJ, Postma AA, Kooi ME. Differentiation of Atherosclerotic Carotid Plaque Components With Dual-Energy Computed Tomography. Invest Radiol. 2025 Aug 1;60(8):508-516. doi: 10.1097/RLI.0000000000001153. Epub 2025 Jan 22.
PMID: 39836610DERIVEDCrombag GAJC, Schreuder FHBM, van Hoof RHM, Truijman MTB, Wijnen NJA, Voo SA, Nelemans PJ, Heeneman S, Nederkoorn PJ, Daemen JH, Daemen MJAP, Mess WH, Wildberger JE, van Oostenbrugge RJ, Kooi ME. Microvasculature and intraplaque hemorrhage in atherosclerotic carotid lesions: a cardiovascular magnetic resonance imaging study. J Cardiovasc Magn Reson. 2019 Mar 4;21(1):15. doi: 10.1186/s12968-019-0524-9.
PMID: 30832656DERIVEDTruijman MT, de Rotte AA, Aaslid R, van Dijk AC, Steinbuch J, Liem MI, Schreuder FH, van der Steen AF, Daemen MJ, van Oostenbrugge RJ, Wildberger JE, Nederkoorn PJ, Hendrikse J, van der Lugt A, Kooi ME, Mess WH; Plaque at RISK Study. Intraplaque hemorrhage, fibrous cap status, and microembolic signals in symptomatic patients with mild to moderate carotid artery stenosis: the Plaque at RISK study. Stroke. 2014 Nov;45(11):3423-6. doi: 10.1161/STROKEAHA.114.006800. Epub 2014 Sep 25.
PMID: 25256179DERIVED
Biospecimen
Carotid plaque removed during carotid endarterectomy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Eline Kooi, PhD
Maastricht University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2012
First Posted
October 17, 2012
Study Start
August 1, 2011
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
October 27, 2023
Record last verified: 2023-10